Recruiting

1/2

48

 

Dose: 1.5g each time for subjects taking the experimental drug and placebo, and 0.5g each time for subjects taking the control drug；D1 was administered once; D2-D12 was administered three times a day; D13 was administered once; ;Dose: 3.0g each time for subjects taking the experimental drug and placebo, and 0.5g each time for subjects taking the control drug；D1 was administered once; D2-D12 was administered three times a day; D13 was administered once; ;Dose: 4.5g each time for subjects taking the experimental drug and placebo, and 0.5g each time for subjects taking the control drug；D1 was administered once; D2-D12 was administered three times a day; D13 was administered once; ;Dose: 6.0g each time for subjects taking the experimental drug and placebo, and 0.5g each time for subjects taking the control drug；D1 was administered once; D2-D12 was administered three times a day; D13 was administered once;

The First Hospital of Jilin University; Grand Life Science (Liaoning) Co., LTD, Development Center for Medical Science & Technology National health and family planning commission of the People's Republic of China

Hyperphosphatemia